Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Market Cap	446.17B
Revenue (ttm)	10.95B
Net Income (ttm)	2.79B
Shares Out	8.13M
EPS (ttm)	-255.76
PE Ratio	159.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,633
Average Volume	131,709
Open	54,600
Previous Close	53,300
Day's Range	53,100 - 56,600
52-Week Range	21,400 - 60,800
Beta	n/a
RSI	59.34
Earnings Date	n/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 389650